USD 0.0
(0.0%)
Breakdown | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
---|---|---|---|---|---|---|
Operating Cash Flow | 34.79 Million | 15.29 Million | -6.67 Million | -1.57 Million | -48.69 Thousand | -89.56 Thousand |
Net Income | -119.45 Million | 29.46 Million | -10.62 Million | -4.97 Million | -47.01 Thousand | -180.87 Thousand |
Depreciation & Amortization | 153.19 Million | 34.8 Million | 28.14 Thousand | 8304.60 | - | - |
Deferred income taxes | -59.31 Million | 41.51 Million | - | - | - | - |
Stock-based compensation | 1.2 Million | 3.89 Million | 4.52 Million | 1.64 Million | - | 84.93 Thousand |
Change in working capital | 26.44 Million | -16.03 Million | -608.14 Thousand | 1.22 Million | -1676.73 | - |
Other non-cash items | 185.91 Million | -36.84 Million | - | 514.53 Thousand | - | 6376.66 |
Investing Cash Flow | 2.94 Million | -239.97 Million | -107.17 Million | -22.97 Million | - | - |
Investments in PPE | -18.08 Million | -22.19 Million | -62.03 Million | -21.7 Million | - | - |
Acquisitions | - | -182.87 Million | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 21.02 Million | -34.9 Million | -45.14 Million | -1.26 Million | - | - |
Financing Cash Flow | -25.88 Million | 229.4 Million | 86.73 Million | 64.43 Million | - | 748.92 Thousand |
Debt repayment | - | -195.58 Million | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 1.35 Million | 20.76 Million | 86.73 Million | 63.88 Million | - | 787.89 Thousand |
Other Financing Activities | -27.23 Million | 404.23 Million | - | 543.49 Thousand | - | -38.96 Thousand |
Accounts receivables | 10.48 Million | -11.89 Million | -1.54 Million | -310.96 Thousand | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | 229 Thousand | -581 Thousand | - | - | - | - |
Other working capital | 15.73 Million | -3.55 Million | 938.85 Thousand | 1.53 Million | - | - |
Cash at beginning of period | 19.8 Million | 15.57 Million | 41.82 Million | 1.13 Million | 690.3 Thousand | - |
Cash at end of period | 31.56 Million | 19.8 Million | 15.58 Million | 40.75 Million | 641.61 Thousand | 659.36 Thousand |
Capital Expenditure | -18.08 Million | -22.19 Million | -62.03 Million | -21.7 Million | - | - |
Effect of forex changes on cash | -99 Thousand | -498 Thousand | 880.55 Thousand | -262.46 Thousand | - | - |
Net cash flow / Change in cash | 11.75 Million | 4.22 Million | -26.24 Million | 39.62 Million | -48.69 Thousand | 659.36 Thousand |
Free Cash Flow | 16.71 Million | -6.9 Million | -68.71 Million | -23.28 Million | -48.69 Thousand | -89.56 Thousand |
Breakdown | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 FY | 2014 Q3 | 2014 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -47.57 Million | -13.54 Million | -48.59 Million | -119.45 Million | -42.48 Million | -28.02 Million |
Depreciation & Amortization | 26.85 Thousand | 6211.00 | 6462.00 | 153.19 Million | 42.31 Thousand | 19.04 Million |
Deferred income taxes | - | - | - | -59.31 Million | - | 3.96 Million |
Stock-based compensation | -96 Thousand | 160 Thousand | 134 Thousand | 1.2 Million | 947 Thousand | 81 Thousand |
Change in working capital | -2.37 Million | -13.49 Million | 10.01 Million | 26.44 Million | 19.76 Million | -4.22 Million |
Other non-cash items | 55.53 Million | 15.55 Million | 45.65 Million | 185.91 Million | 22.26 Million | 27.32 Million |
Investing Cash Flow | -5.39 Million | -9.73 Million | -3.22 Million | 2.94 Million | 7.04 Million | -818 Thousand |
Investments in PPE | -4.9 Million | -10.55 Million | -7.82 Million | -18.08 Million | -6.65 Million | -427 Thousand |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -489 Thousand | 818 Thousand | 4.59 Million | 21.02 Million | 13.7 Million | -391 Thousand |
Financing Cash Flow | -94 Thousand | -172 Thousand | -319 Thousand | -25.88 Million | -12.17 Million | -324 Thousand |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 442 Thousand | 1.35 Million | - | - |
Other Financing Activities | -94.00 | -172.00 | -761 Thousand | -27.23 Million | -12.17 Million | -324 Thousand |
Accounts receivables | -1.07 Million | -1.13 Million | 11.63 Million | 10.48 Million | 4.03 Million | -5.67 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | -1.17 Million | -207 Thousand | 318 Thousand | 229 Thousand | -650 Thousand | 688 Thousand |
Other working capital | -122 Thousand | -12.14 Million | -1.94 Million | 15.73 Million | 16.38 Million | 764 Thousand |
Cash at beginning of period | 10.2 Million | 31.56 Million | 28.02 Million | 19.8 Million | 32.81 Million | 34.71 Million |
Cash at end of period | 10.27 Million | 10.2 Million | 31.56 Million | 31.56 Million | 28.02 Million | 32.81 Million |
Capital Expenditure | -4.9 Million | -10.55 Million | -7.82 Million | -18.08 Million | -6.65 Million | -427 Thousand |
Effect of forex changes on cash | 69 Thousand | -115 Thousand | -127 Thousand | -99 Thousand | -151 Thousand | 124 Thousand |
Net cash flow / Change in cash | 66 Thousand | -21.35 Million | 3.53 Million | 11.75 Million | -4.79 Million | -1.89 Million |
Free Cash Flow | 580 Thousand | -21.88 Million | -616 Thousand | 16.71 Million | -6.16 Million | -1.3 Million |
GSK
DHANUKA
AMNZF
LRE
VEERKRUPA
OROSMITHS